Abstract Library

#4311 Characterisation of patients diagnosed with metastatic head and neck paraganglioma treated at an oncology referral institution in Colombia

Introduction: Head and neck paragangliomas (HNPGL) are rare tumours. Multiple risk factors associated with the risk of metastasis have been described, although much of the available information corresponds to the group of Pheochromocytoma and Paragangliomas, not necessarily extrapolatable to metastatic HNPGLs.

Conference:

Presenting Author: Fierro L

Authors: González A, Puerto J, Fierro L, Zarama A, Caicedo L,

Keywords: Paraganglioma, head and neck, metastasis, survival,

#3887 Characteristics and management of high grade gastroenteropancreatic neuroendocrine neoplasms – A Belgian retrospective analysis from the DNET & NETwerk registry

Introduction: High grade gastroenteropancreatic neuroendocrine neoplasms (HG-GEPNEN) comprise neuroendocrine carcinoma (NEC) and well-differentiated neuroendocrine tumors (NETG3). These entities exhibit many differences in behaviour, prognosis and sensitivity to chemotherapy. Data about their optimal management are still scarce.

Conference:

Presenting Author:

Authors: Islam O, Sarti K, Verslype C, van Laethem J, Kalantari Hassan R,

Keywords: Neuroendocrine tumor, high-grade gastroenteropancreatic NEN (HG GEPNEN), neuroendocrine carcinoma, neuroendocrine tumor g3, retrospective data, clinical data, pathology,

#3345 Integrative molecular analysis of combined small-cell lung carcinoma reveals EGFR and KRAS mutational analysis as the theragnostic tools in whole small cells lung carcinoma landscape

Introduction: Combined small-cell lung cancer (C-SCLC) are composed of SCLC admixed with a non-small-cell cancer component. They currently receive the same treatment as SCLC. The recent evidence that SCLC may belong to either of 2 lineages, neuroendocrine or non-neuroendocrine, with different vulnerability to specific cell death pathways such as ferroptosis, opens new therapeutic opportunities also for C-SCLC.

Conference:

Presenting Author:

Authors: Simbolo M, Centonze G, Ali G, Ciaparrone C, Grillo F,

Keywords: Combined small cell lung carcinoma, small cell lung cancer, neuroendocrine carcinoma, next generation sequencing, transcriptomics,

#3189 Real-world outcomes of patients with neuroendocrine liver metastases treated with trans-arterial radioembolization: Results from CIRT, a large European prospective multi-centre observational study

Introduction: Trans-arterial radioembolization (TARE) is a treatment option for patients with liver dominant metastases from neuroendocrine tumors (mNET). The CIRSE Registry for SIR-Spheres Therapy (CIRT) is a European prospective multi-centre observational study conducted by the Cardiovascular and Interventional Radiological Society of Europe (CIRSE).

Conference: 18th Annual ENETS Concerence (2021)

Presenting Author: Helmberger T

Authors: Helmberger T, Schaefer N, Pech M, Pfammatter T, Maleux G,

Keywords: liver metastases, observational study, yttrium-90, trans-arterial radioembolization, registry, therapeutic embolization, SIRT,

#1162 Comparative Marker Assessment in Small Cell Lung Cancer with Good and Poor Prognosis

Introduction: Small cell lung cancers (SCLC) are highly aggressive and poorly differentiated neuroendocrine neoplasms which comprise ̴̴̴15 % of all lung malignancies.

Conference: 12th Annual ENETSConcerence (2015)

Presenting Author:

Authors: Schmidt L, Specht E, Reimann C, Kaemmerer D, Wirtz R,

Keywords: SCLC, SSTR, CXCR4, proliferation,